Lansoprazole Capsules
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DLA TROOP SUPPORT
Contract Value
Not provided
Codes & Classification
Solicitation Number
SPE2D2-25-D-0014
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
6505
Additional Details
Documents1
The Defense Logistics Agency (DLA) Troop Support has issued an award notice under procurement identifier SPE2D2-25-D-0014 for the supply of Lansoprazole Capsules. This procurement falls under the North American Industry Classification System (NAICS) code 325412, which pertains to Pharmaceutical Preparation Manufacturing, and is further classified under Product Service Code (PSC) 6505, indicating drugs and biologicals.
The primary objective of this procurement is to secure a reliable supply of Lansoprazole Capsules, a pharmaceutical product commonly used to treat certain stomach and esophagus problems such as acid reflux. The intended outcome is to ensure the availability of this essential medication for the agency’s operational requirements, supporting the health and readiness of personnel.
The place of performance for this contract is specified as Guadalajara, Jalisco, Mexico (MX-JAL), indicating that manufacturing or supply activities will be conducted at this location. This international aspect may require contractors to have established capabilities or partnerships in Mexico, as well as compliance with relevant regulatory standards for pharmaceutical manufacturing and export.
DLA Troop Support, a federal office, serves as the contracting entity for this award. The primary point of contact for this procurement is Jeremy Brown, who can be reached at [email protected] or by phone at 215-737-6031. A secondary contact is Jason Wray, available at [email protected] or 215-737-0614. These contacts can provide further clarification regarding contract requirements or administrative procedures.
The notice is currently active and was posted on June 18, 2025. Interested parties can access the official award notice and any associated attachments via the SAM.gov opportunity ID c46318838ba2410faf75e92156a83b76, or directly through the provided URL.
While the notice does not specify set-aside requirements or special considerations, contractors should note the federal nature of the procurement and the expectation for compliance with all applicable regulations governing pharmaceutical manufacturing and supply to the U.S. government. The contract’s scope and deliverables are centered on the consistent and timely provision of Lansoprazole Capsules, with quality and regulatory adherence being paramount.
This opportunity is best suited for contractors with demonstrated experience in pharmaceutical preparation manufacturing, particularly those with operational capacity in Mexico or the ability to coordinate international supply chains. The long-term nature of the contract suggests a need for sustained performance and reliability throughout the contract lifecycle.